Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Fortress Biotech (FBIO) Long-Term Debt Issuances (2016 - 2024)

Historic Long-Term Debt Issuances for Fortress Biotech (FBIO) over the last 11 years, with Q4 2024 value amounting to -$33.7 million.

  • Fortress Biotech's Long-Term Debt Issuances fell 22042.14% to -$33.7 million in Q4 2024 from the same period last year, while for Sep 2024 it was $61.7 million, marking a year-over-year increase of 113436.0%. This contributed to the annual value of $28.0 million for FY2023, which is 46000.0% up from last year.
  • As of Q4 2024, Fortress Biotech's Long-Term Debt Issuances stood at -$33.7 million, which was down 22042.14% from $33.7 million recorded in Q3 2024.
  • Fortress Biotech's 5-year Long-Term Debt Issuances high stood at $42.1 million for Q1 2022, and its period low was -$42.1 million during Q2 2022.
  • In the last 4 years, Fortress Biotech's Long-Term Debt Issuances had a median value of $7.0 million in 2021 and averaged $4.4 million.
  • As far as peak fluctuations go, Fortress Biotech's Long-Term Debt Issuances surged by 46000.0% in 2023, and later plummeted by 22042.14% in 2024.
  • Over the past 4 years, Fortress Biotech's Long-Term Debt Issuances (Quarter) stood at $7.0 million in 2021, then dropped by 28.57% to $5.0 million in 2022, then soared by 460.0% to $28.0 million in 2023, then crashed by 220.42% to -$33.7 million in 2024.
  • Its Long-Term Debt Issuances stands at -$33.7 million for Q4 2024, versus $33.7 million for Q3 2024 and $28.0 million for Q4 2023.